Literature DB >> 21722250

Ebola and Marburg haemorrhagic fever viruses: major scientific advances, but a relatively minor public health threat for Africa.

E M Leroy1, J-P Gonzalez, S Baize.   

Abstract

Ebola and Marburg viruses are the only members of the Filoviridae family (order Mononegavirales), a group of viruses characterized by a linear, non-segmented, single-strand negative RNA genome. They are among the most virulent pathogens for humans and great apes, causing acute haemorrhagic fever and death within a matter of days. Since their discovery 50 years ago, filoviruses have caused only a few outbreaks, with 2317 clinical cases and 1671 confirmed deaths, which is negligible compared with the devastation caused by malnutrition and other infectious diseases prevalent in Africa (malaria, cholera, AIDS, dengue, tuberculosis …). Yet considerable human and financial resourses have been devoted to research on these viruses during the past two decades, partly because of their potential use as bioweapons. As a result, our understanding of the ecology, host interactions, and control of these viruses has improved considerably.
© 2011 The Authors. Clinical Microbiology and Infection © 2011 European Society of Clinical Microbiology and Infectious Diseases.

Entities:  

Mesh:

Year:  2011        PMID: 21722250     DOI: 10.1111/j.1469-0691.2011.03535.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  47 in total

1.  A single sublingual dose of an adenovirus-based vaccine protects against lethal Ebola challenge in mice and guinea pigs.

Authors:  Jin Huk Choi; Stephen C Schafer; Lihong Zhang; Gary P Kobinger; Terry Juelich; Alexander N Freiberg; Maria A Croyle
Journal:  Mol Pharm       Date:  2011-12-15       Impact factor: 4.939

2.  Mechanism of Binding to Ebola Virus Glycoprotein by the ZMapp, ZMAb, and MB-003 Cocktail Antibodies.

Authors:  Edgar Davidson; Christopher Bryan; Rachel H Fong; Trevor Barnes; Jennifer M Pfaff; Manu Mabila; Joseph B Rucker; Benjamin J Doranz
Journal:  J Virol       Date:  2015-08-26       Impact factor: 5.103

Review 3.  Emerging targets and novel approaches to Ebola virus prophylaxis and treatment.

Authors:  Jin Huk Choi; Maria A Croyle
Journal:  BioDrugs       Date:  2013-12       Impact factor: 5.807

Review 4.  Ebola virus disease.

Authors:  Nicholas J Beeching; Manuel Fenech; Catherine F Houlihan
Journal:  BMJ       Date:  2014-12-10

5.  Understanding organ dysfunction in Ebola virus disease.

Authors:  Tom E Fletcher; Robert A Fowler; Nicholas J Beeching
Journal:  Intensive Care Med       Date:  2014-11-01       Impact factor: 17.440

Review 6.  Ecological dynamics of emerging bat virus spillover.

Authors:  Raina K Plowright; Peggy Eby; Peter J Hudson; Ina L Smith; David Westcott; Wayne L Bryden; Deborah Middleton; Peter A Reid; Rosemary A McFarlane; Gerardo Martin; Gary M Tabor; Lee F Skerratt; Dale L Anderson; Gary Crameri; David Quammen; David Jordan; Paul Freeman; Lin-Fa Wang; Jonathan H Epstein; Glenn A Marsh; Nina Y Kung; Hamish McCallum
Journal:  Proc Biol Sci       Date:  2015-01-07       Impact factor: 5.349

7.  Distinct Immunogenicity and Efficacy of Poxvirus-Based Vaccine Candidates against Ebola Virus Expressing GP and VP40 Proteins.

Authors:  Adrián Lázaro-Frías; Sergio Gómez-Medina; Lucas Sánchez-Sampedro; Karl Ljungberg; Mart Ustav; Peter Liljeström; César Muñoz-Fontela; Mariano Esteban; Juan García-Arriaza
Journal:  J Virol       Date:  2018-05-14       Impact factor: 5.103

8.  Ebola virus disease: history, epidemiology and outbreaks.

Authors:  Jacqueline Weyer; Antoinette Grobbelaar; Lucille Blumberg
Journal:  Curr Infect Dis Rep       Date:  2015-05       Impact factor: 3.725

9.  Pathogenicity Comparison Between the Kikwit and Makona Ebola Virus Variants in Rhesus Macaques.

Authors:  Gary Wong; Xiangguo Qiu; Marc-Antoine de La Vega; Lisa Fernando; Haiyan Wei; Alexander Bello; Hugues Fausther-Bovendo; Jonathan Audet; Andrea Kroeker; Robert Kozak; Kaylie Tran; Shihua He; Kevin Tierney; Geoff Soule; Estella Moffat; Stephan Günther; George F Gao; Jim Strong; Carissa Embury-Hyatt; Gary Kobinger
Journal:  J Infect Dis       Date:  2016-09-19       Impact factor: 5.226

10.  Why has the Ebola outbreak in West Africa been so challenging to control?

Authors:  T Semalulu; G Wong; G Kobinger; P Huston
Journal:  Can Commun Dis Rep       Date:  2014-08-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.